BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35845523)

  • 21. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
    Machens A; Schneyer U; Holzhausen HJ; Dralle H
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2029-34. PubMed ID: 15634717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
    Zhu Q; Xu D
    BMC Cancer; 2021 Apr; 21(1):344. PubMed ID: 33794811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and significance of indeterminate calcitonin values in patients with thyroid nodules: A systematic review and meta-analysis.
    Piticchio T; Frasca F; Trimboli P
    Rev Endocr Metab Disord; 2023 Aug; 24(4):685-694. PubMed ID: 37254023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.
    Eckelt F; Pfaeffle R; Kiess W; Kratzsch J
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1491-1504. PubMed ID: 34543539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing.
    Pomares FJ; Rodríguez JM; Nicolás F; Sola J; Canteras M; Balsalobre M; Pascual M; Parrilla P; Tébar FJ
    J Am Coll Surg; 2002 Nov; 195(5):630-4. PubMed ID: 12437249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of Serum Calcitonin in Patients with Thyroid Nodules ≤ 1 cm Without an Indication for Fine-Needle Aspiration.
    Rosario PW; Mourão GF; Calsolari MR
    Horm Metab Res; 2020 Apr; 52(4):216-219. PubMed ID: 32168524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative Serum Calcitonin Level and Ultrasonographic Characteristics Predict the Risk of Metastatic Medullary Thyroid Carcinoma: Functional Analysis of Calcitonin-Related Genes.
    Fan Y; Xu H; Lv M; Li N
    Dis Markers; 2022; 2022():9980185. PubMed ID: 35280443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma.
    Censi S; Bertazza L; Piva I; Manso J; Benna C; Iacobone M; Mondin A; Plebani M; Faggian D; Galuppini F; Pennelli G; Barollo S; Mian C
    Front Endocrinol (Lausanne); 2021; 12():647369. PubMed ID: 33854485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
    Yip DT; Hassan M; Pazaitou-Panayiotou K; Ruan DT; Gawande AA; Gaz RD; Moore FD; Hodin RA; Stephen AE; Sadow PM; Daniels GH; Randolph GW; Parangi S; Lubitz CC
    Surgery; 2011 Dec; 150(6):1168-77. PubMed ID: 22136837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
    Kwon H; Kim WG; Jeon MJ; Song DE; Lee YM; Sung TY; Chung KW; Yoon JH; Hong SJ; Baek JH; Lee JH; Kim TY; Kim WB; Shong YK
    Endocrine; 2016 Jul; 53(1):174-81. PubMed ID: 26754662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Utility of Procalcitonin for Sporadic Medullary Thyroid Carcinoma in Patients with Nodular Disease and Mild or Moderate Hypercalcitoninemia.
    Rosario PW; Mourão GF
    Horm Metab Res; 2022 Apr; 54(4):220-223. PubMed ID: 35413742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
    Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
    Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [
    Rasul S; Hartenbach S; Rebhan K; Göllner A; Karanikas G; Mayerhoefer M; Mazal P; Hacker M; Hartenbach M
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2159-2169. PubMed ID: 29766245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma.
    Park H; Park J; Choi MS; Kim J; Kim H; Shin JH; Kim JH; Kim JS; Kim SW; Chung JH; Kim TH
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
    Kwon H; Kim WG; Choi YM; Jang EK; Jeon MJ; Song DE; Baek JH; Ryu JS; Hong SJ; Kim TY; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):598-603. PubMed ID: 25041034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
    Machens A; Lorenz K; Dralle H
    Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma.
    Trimboli P; Peloni G; Confalonieri D; Gamarra E; Piticchio T; Frasca F; Makovac P; Piccardo A; Ruinelli L
    Front Oncol; 2024; 14():1278816. PubMed ID: 38347847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.